In recent years, miR-145 has been identified as a significant player in urological tumors, not only by directly regulating oncogenic signaling pathways but also by influencing the tumor microenvironment through the modulation of immune checkpoint molecules, such as PD-L1. Here, CD274 is linked to neoplasm.